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Introduction
Glaucoma is the second most com-
mon cause of blindness in the devel-
oped world (Kingman 2004). While
intraocular pressure (IOP) lowering
strategies have been the mainstay of
glaucoma treatment, a signiﬁcant
number of patients still progress
despite an otherwise successful reduc-
tion in this major risk factor (Leske
et al. 2003; Parc et al. 2001). The vast
majority of the studies regarding non-
IOP-related risk factors such as vascu-
lar disturbances have focused on the
arterial component. In fact, patients
with primary open-angle glaucoma
(POAG) but particularly the ones
without increased IOP (normal ten-
sion glaucoma, NTG) have been
found to have an altered systemic and
ocular circulation, ranging from
decreased ocular perfusion pressures
and blood ﬂow velocities (Stalmans
et al. 2009; Garho¨fer et al. 2010) to
vascular endothelial dysfunction and
defective autoregulation (Fadini et al.
2010; Flammer & Mozaffarieh 2008;
Resch et al. 2009a,b). However, glau-
coma is also linked to venous diseases,
being one of the main risk factors for
central vein occlusion (The Eye Dis-
ease Case–Control Study Group
1996). Current evidence suggests this
relation may be more important than
previously thought, with a number of
authors describing increased glaucoma
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ABSTRACT.
Purpose: Recently, the absence of spontaneous venous pulsation (SVP) has been
suggested as a vascular risk factor for primary open-angle glaucoma (POAG).
As the mechanism behind this phenomenon is still unknown, the authors have
studied this vascular component using colour Doppler imaging (CDI).
Methods: A total of 236 patients were divided into three diagnostic groups:
healthy controls (81), POAG (86) and normal tension glaucoma (NTG; 69). All
subjects were submitted to CDI studies of the retrobulbar circulation, intraocular
pressure measurements and assessment of SVP existence. Mann–Whitney, chi-
square contingency tables and Spearman correlations were used to explore dif-
ferences and correlations between variables in the diagnostic groups.
Results: Eighty-two percent of healthy controls had SVP (66 ⁄81), while a smaller
numbers were registered in both glaucoma groups: POAG – 50% (43 ⁄86); NTG –
51% (35 ⁄69). In NTG patients, but not in POAG patients, the prevalence of the
SVP phenomenon decreases with increased glaucoma damage (p = 0.04; p = 0.55,
respectively). Overall glaucoma patients from both groups had lower central retinal
vein (CRV) velocities than the healthy controls (p < 0.05). NTG patients with SVP
had less severe visual ﬁeld defects (mean defect )6.92 versus )11.1, p < 0.05),
higher [correction added after online publication 21 September 2012; the word
‘higher’ has been inserted to replace the word ‘lower’] peak systolic and mean ﬂow
velocities in the central retinal artery (p < 0.01; p < 0.05, respectively) as well as
higher [correction added after online publication 21 September 2012; the word
higher has been inserted to replace the word lower] maximal velocities and RI of the
CRV (p < 0.02; p < 0.05, respectively).
Conclusions: Glaucoma patients have a decrease in CRV velocities. SVP is
less prevalent in glaucoma patients than in healthy individuals. This phenome-
non apparently reﬂects different hemodynamic patterns in the central retinal
vessels. This variable may be of particular importance in NTG patients, where
it may be associated with more advanced functional damage.
Key words: colour Doppler imaging – glaucoma – normal tension glaucoma – spontaneous
venous pulsation – vascular dysfunction
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progression in patients with increased
venous pulse pressure (Morgan et al.
2005; Balaratnasingam et al. 2007).
Evidence of this disturbance in the
venous circulation is raising, ranging
from increased episcleral venous pres-
sure (Selbach et al. 2005), to a possi-
ble role in the appearance of optic
disc haemorrhages (Krakau 1994).
Additionally, glaucoma patients have
a signiﬁcant decrease in prevalence of
the spontaneous venous pulsation
(SVP) phenomenon over the optic
disc, which can be found in up to
98% of the general population (Mor-
gan et al. 2004; Legler & Jonas 2009).
Classically, this sign has been used to
evaluate patients with papiledema,
Graves’ orbitopathy and as a prog-
nostic sign in central vein occlusions
(Jonas & Harder 2003; Jonas 2003;
Jonas 2004a,b). While the debate over
the mechanisms involved in this
absent pulsation is still ongoing, data
suggest this may reﬂect an imbalance
between the intra- and extraocular
compartments pressure pulses (Don-
nelly & Subramanian 2009; Nowrooz-
zadeh & Saki 2009; Kain et al. 2010).
Interestingly, and despite the clinical
relevance of this venous vascular com-
ponent, there have been no studies on
the ocular blood ﬂow in these patients
that can help determine whether this
venous alteration is part of a larger
vascular dysregulation. Colour Dopp-
ler imaging (CDI) technology has
been a well-validated tool in ocular
blood ﬂow research (Stalmans et al.
2011; Founti et al. 2011), providing
an increasing amount of relevant
information to glaucoma studies,
including on vascular dysregulation
(Abega˜o Pinto et al. 2012).
Our study aimed to investigate dif-
ferences in the retrobulbar circulation
in glaucoma patients with and without




Three cohorts of individuals over
18 years old were recruited for the
study: patients with NTG (n = 69),
patients with POAG (n = 86) and
healthy control subjects (n = 81) of
comparable age. This latter group was
recruited from the persons accompa-
nying the patients. Glaucoma patients
were deﬁned as having characteristic
optic disc damage and visual ﬁeld loss
(Jamel 1997; Zeyen 1999). For the
diagnosis of POAG, an untreated IOP
of 21 mmHg or greater was required.
Current medical treatment, including
topical IOL lowering drugs, was con-
tinued. The healthy volunteers were
screened by a senior member of the
glaucoma clinic (IST). Those with a
family history of glaucoma, an
increased or asymmetrical cup ⁄disc
ratio or any other optic disc structural
change (notching, disc haemorrhage)
or an IOP above 21 mmHg were con-
sidered as possible glaucoma suspects
and excluded. Patients with a history
of ocular trauma or any known eye
disease other than glaucoma were
excluded. A history of ocular venous
obstruction (branch or central occlu-
sion) or systemic conditions associated
with venous congestion (e.g. heart fail-
ure) was also considered to be exclu-
sion criteria. Additionally, any optic
disc abnormality or arteries’ disposi-
tion that precluded the observation of
the veins over the optic disc was also
excluded.
Information regarding functional
and structural damage from glaucoma
patients was collected from examina-
tions undertaken on the day of the
study visit.
Measuring devices
Visual acuity was tested using the
Early Treatment of Diabetic Retinop-
athy Study (ETDRS) chart. The chart
was placed in the same location at the
same distance from the patient under
the same illumination for all subjects.
IOP was measured with the Gold-
mann applanation tonometer (GAT).
Blood pressure measurement was
taken from subject’s right arm using
an electronic sphygmomanometer
(Omron, Schaumburg, IL, USA). Ret-
robulbar ﬂow velocities [peak systolic
velocity (PSV), end diastolic velocity
(EDV), mean ﬂow velocity (MFV),
maximum venous velocity (Vmax),
minimum venous velocity (Vmin) and
resistivity index (RI)] of the central
retinal artery and vein [CRA and cen-
tral retinal vein (CRV), respectively],
nasal and temporal short posterior cil-
iary arteries (NPCA and TPCA,
respectively) and ophthalmic artery
(OA) were measured with the Antares
CDI device (Siemens, Munich,
Germany). Observation of the optic
disc was performed with a fundus
camera (Topcon TRC-50DX ⁄EX fun-
dus camera; Topcon Medical Systems,
Inc, Oakland, NJ, USA).
Experimental design
Patients were instructed to avoid caf-
feine intake, smoking and exercise for
3 hr prior to the study visit. The study
was approved by the ethical commit-
tee (Institutional Review Board) at
the University Hospitals Leuven and
was conducted in accordance with
Good Clinical Practice within the
tenets of the Helsinki agreement. Each
patient ⁄ subject was required to sign
an informed consent statement before
being enrolled in the study and prior
to any study measurements being
taken. During the study visit, the fol-
lowing examinations were performed
in the same order: visual acuity, IOP
measurement by GAT, blood pressure
and heart rate measurements, CDI
and ﬁnally SVP assessment. This latter
examination was performed using the
following protocol: pharmacological
dilation of the selected eye with trop-
icamide 0.5% (Tropicol, The´a
Pharma, Wetteren, Belgium), observa-
tion of the optic disc for at least
1 min using a fundus camera. Venous
pulsations over the optic disc were
described as either present ⁄absent,
and any asymmetry in superior ⁄ infe-
rior pulsation was recorded. These last
two examinations (CDI and SVP
assessment) were performed by a sin-
gle observer (LAP) masked to the
patient diagnosis. Only one eye per
patient was included in the study. The
eye with greater glaucomatous dam-
age was selected in the glaucoma
patients and a randomly selected eye
in the healthy individuals.
Statistical analysis
Chi-square tests (for 3 · 2 contin-
gency tables) were used to analyse the
spontaneous ⁄absent venous pulsation
ratios. Kruskal–Wallis tests were used
to compare the three diagnostic
groups on different variables. Mann–
Whitney test was used in pairwise
comparisons. The existence of correla-
tion was explored using Spearman’s
correlation. Statistical signiﬁcance was
considered when p < 0.05. Values are
depicted as mean ± SD unless
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otherwise indicated. Analyses were
performed using Graphpad Prism




Table 1 summarizes the patient char-
acteristics in the different diagnostic
groups. Kruskall–Wallis test indicated
no overall differences between the
studied groups in age, blood pressure
(BP) systolic and median ocular perfu-
sion pressure (MOPP) (p ranged from
0.13 to 0.91). The overall difference in
diastolic BP that was detected between
the three groups (p < 0.01) did not
reach signiﬁcance when comparing
between the two glaucoma groups
(p = 0.12) using a Mann–Whitney
test. We identiﬁed statistically signiﬁ-
cant differences in visual acuity and
IOP when comparing between the
three groups (p < 0.01), which were
judged clinically not unexpected nor
relevant for the study. As expected,
there was a signiﬁcant difference in
functional and structural parameters
of glaucoma damage between the
three groups (MD and RNFL thick-
ness: p < 0.001). However, when
comparing between the two glaucoma
groups, no difference was detected
(MD: p = 0.79; RNFL thickness:
p = 0.90). A statistical signiﬁcance
between the SVP status in the three
groups existed, with the healthy group
having a higher prevalence of this
phenomenon (66 of 81 = 82%) when
compared to both POAG (43 of
86 = 50%) and NTG groups (35 of
69 = 51%). No difference was
detected when comparing both glau-
coma groups (p = 0.75). Topical
medications in both glaucoma SVP
subgroups (with ⁄without the SVP phe-
nomenon) are summarized in Table 2.
Experimental groups by SVP status
Table 3 summarizes the analysis of
the two subdivision within each exper-
imental group according to their SVP
status. In the healthy group, no differ-
ences were detected between patients
that presented SVP to those who did
not, regarding the ocular and systemic
variables currently studied. In the
POAG group, the only differences
between the two sets of patients was a
signiﬁcantly higher MOPP and dia-
stolic blood pressures (p < 0.01) in
the patients who did not present SVP.
The only statistically signiﬁcant differ-
ence in the NTG group was a signiﬁ-
cantly higher functional damage in
patients without SVP (p < 0.05)
despite a similar degree of structural
damage (p = 0.68).
Despite an overall similarity in SVP
prevalence in both POAG and NTG
groups (50% and 51%, respectively;
p = 0.72), further analysis of this
prevalence according to the degree of
glaucoma damage revealed differences
between the two glaucoma groups
(Fig. 1). In the NTG group, SVP
prevalence decreased with increased
functional damage, from 73% (11 of
15) in patients between +2 and )2 dB
to 56% (15 of 27) in patients between
)2 and )10 dB, and 33% (nine of 27)
in patients with MD above )10 dB
(p = 0.04). In the POAG group, no
differences in SVP prevalence were
detected (MD between +2 and
)2 dB: 10 of 18 = 56%; MD between
)2 and )10 dB: 15 of 35 = 43%;
MD above )10 dB: 18 of 33 = 55%;
p = 0.55).
Retrobulbar ﬂow velocities in glaucoma
patients and healthy controls
The blood ﬂow velocities obtained by
CDI of the retrobulbar vessels (CRA,
NPCA, TPCA, OA and CRV) of the
overall groups and their statistical
comparison are described in Table 4.
Table 5 depicts the data from the
CDI examinations according to the
SVP status of the three experimental
groups. Healthy patients without SVP
had a higher Vmin than their SVP posi-
tive counterpart (p < 0.05). POAG
patients who did not show SVP, on the
other hand, had lower CRV Vmin and
RI than POAG patients with SVP
(p < 0.02; p < 0.05, respectively).
The NTG SVP-absent subgroup had
signiﬁcantly lower central retinal artery
PSV and MFV (p < 0.01; p < 0.05,
respectively), as well as lower Vmax
and RI of the CRV (p < 0.02;
p < 0.05, respectively) than the NTG
patients with SVP phenomenon. No
other differences were detected in any
of the other pairwise comparisons
(p > 0.05).
Discussion
This study was conducted to identify
characteristics that could be associated
with the SVP phenomenon in
glaucoma. Secondly, we checked
whether any differences in such vari-
Table 1. Patients characteristics.
Healthy, n (%) NTG, n (%) POAG, n (%) Overall (p-value) Pairwise NTG versus POAG (p-value)
n 81 69 86
Age 64.6 (14) 69.3 (11) 67.4 (12) 0.13 0.45
IOP 16.0 (4.8) 12.3 (2.8) 14.8 (5.0) <0.001 <0.001
Visual acuity 0.15 (0.3) 0.27 (0.3) 0.21 (0.3) <0.01 0.11
SVP+ 66 (81) 35 (51) 43 (50) <0.001 0.75
MD )0.6 (3.9) )8.94 (8.4) )9.3 (8.6) <0.001 0.79
RNFL thickness 0.24 (0.1) 0.15 (0.1) 0.15 (0.1) <0.001 0.90
Pachymetry 577 (57) 553 (35) 555 (36) 0.03 0.73
Systolic BP 151 (21) 152 (24) 151 (22) 0.91 0.70
Diastolic BP 81.8 (12) 84.3 (13) 86.9 (12) <0.01 0.12
MOPP 55.5 (9.9) 58.9 (9.3) 57.4 (10) 0.16 0.34
Mean values (and SD) are depicted. SVP refers to number of patients who presented that phenomenon compared to the total number of patients.
Overall comparisons between the groups were made using the Kruskal–Wallis test. NTG versus POAG comparison was made using Mann–Whit-
ney test. The differences in prevalence of SVP between the groups, however, were performed using a chi-square contingency table (3 · 2). SVP+
indicates the presence of spontaneous venous pulsation; IOP = intraocular pressure; MD = mean defect; RNFL = retinal nerve ﬁbre layer;
BP = blood pressure; MOPP = median ocular perfusion pressure ([2 ⁄ 3 diastolic + 1 ⁄ 3 systolic BPs]*2 ⁄ 3-Goldmann tonometry).
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ables existed between NTG and
POAG patients.
Both glaucoma populations pre-
sented a lower prevalence of the SVP
phenomenon when compared to the
healthy population. While this phe-
nomenon has been previously
described to occur in glaucoma (Mor-
gan et al. 2004; Legler & Jonas 2009),
no data existed concerning NTG
patients speciﬁcally. However, there
are signiﬁcant differences in both
glaucoma groups regarding this phe-
nomenon. In NTG patients, the pul-
sating phenomenon prevalence
decreased signiﬁcantly with more
advanced glaucomatous visual ﬁeld
damage, a relation we failed to detect
in POAG patients. Our data suggest
that the SVP phenomenon has a dif-
ferent meaning depending on the type
of glaucoma. One possible explanation
for this may be that the arterial vascu-
lar dysfunction, known to exist in
glaucoma patients, also has an effect
on the venous circulation. Endothelin,
a well-known vasoconstrictor agent
with a likely link to glaucoma (Shosh-
ani et al. 2012), has a strong impact
on the venous endothelium (Gao &
Raj 2005). Interestingly, it has been
shown to be increased in patients with
retinal vein occlusions (Iannaccone
et al. 1998) as well as patients with
both branch occlusions and NTG (Sin
et al. 2011). In other vascular beds,
such as in the lungs, veins have a
nearly tenfold higher sensibility to
endothelin than the corresponding
arteries (Wang & Coceani 1992). In
conditions of ischaemia and hypoxia,
there is a known effect of hypertrophy
and increased resistance of an other-
wise very low resistance vascular bed
(Takahashi et al. 2011). This process
can even lead to an arterialization
phenomenon of the vein to occur in
such environment. In the ocular circu-
lation, recent reports have been made
about arterial-like endothelial recep-
tors in the CRV in the postlamina
cribosa segment (Kang et al. 2011).
Several studies using endothelin recep-
tor antagonists have detected an
impact on retinal venous ﬂow (Polak
et al. 2003; Resch et al. 2009a,b).
Furthermore, as veins are structur-
ally more fragile than their arterial
counterparts, they are also more liable
to mechanic compression. The glau-
coma-associated deformation of the
pores in the lamina cribosa might act
as an outside compressing structure,
thereby interfering in venous output
and increasing vascular resistance,
thus providing an additional mechani-
cal explanation to the lack of pulsa-
tion.
The presumed increase in retinal
venous pressure, implied in the
absence of the pulsating phenomenon,
has a direct consequence on the perfu-
sion pressure. Calculations regarding
ocular perfusion assume for practical
reasons that retinal veins have similar
values as IOP. Because in non-pulsat-
ing patients the retinal venous
pressure is higher than IOP by an
undetermined amount, the calculated
MOPP is necessarily overestimated









POAG SVP+ 20 (47) 5 (12) 10 (23) 26 (60)
SVP) 22 (51) 3 (7) 11 (16) 27 (63)
NTG SVP+ 14 (40) 3 (9) 12 (34) 12 (34)
SVP) 12 (35) 3 (9) 12 (35) 16 (47)
Number of patients and percentage (between brackets) are depicted.
Table 3. Characteristics of the experimental groups according to SVP status.
Healthy POAG NTG
SVP+ SVP) SVP+ SVP) SVP+ SVP)
n 66 15 43 43 35 34
Age 65.8 (14) 59.3 (14) 67.6 (13) 67.3 (12) 69.0 (11) 70.0 (11)
IOP 16.1 (4.9) 15.3 (4.8) 15.9 (5.8) 13.9 (4.1) 12.3 (3.1) 12.4 (2.5)
CCT 583 (55) 564 (62) 558 (32) 553 (39) 547 (31) 563 (35)
Systolic BP 150 (19) 154 (28) 148 (20) 153 (24) 152 (21) 153 (28)
Diastolic BP 81.3 (10) 84.4 (18) 83.5 (12) 90 (11)** 82.6 (15) 86.0 (11)
MOPP 54.9 (8.6) 57.8 (14) 54.5 (8.6) 60.2 (11)** 58.1 (9.5) 59.7 (9.2)
MD )1.21 (4.1) 0.48 (2.6) )9.86 (9.4) )8.76 (7.8) )6.92 (7.8) )11.1 (8.7)*
RNFL thickness 0.23 (0.1) 0.24 (0.1) 0.16 (0.1) 0.15 (0.1) 0.16 (0.1) 0.15 (0.1)
Data shown as mean (SD). Comparison between the subgroups was made using Mann–Whitney tests. *,** Indicated statistically signiﬁcant differ-
ences in pairwise comparison with SVP+ counterpart (p < 0.05; p < 0.01, respectively). POAG = primary open-angle glaucoma; NTG = nor-
mal tension glaucoma; SVP = spontaneous venous pulsation; IOP = intraocular pressure; CCT = central corneal thickness; BP = blood
pressure; MOPP = mean ocular perfusion pressure ([2 ⁄ 3 diastolic+1 ⁄ 3 systolic BPs]*2 ⁄ 3-Goldmann tonometry); MD = mean defect;




























Fig. 1. Spontaneous venous pulsation preva-
lence in the three diagnostic groups. Glau-
coma groups are divided into three categories
according to increased functional damage cri-
teria: mild – MD between +2 and )2 dB;
moderate – MD between )2 and )10 dB;
severe – MD above )10 dB. Values presented
in percentage. p-Values represent overall
comparison between each group categories.
Statistical tests performed with chi-square
contingency tables (3 · 2).
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(Morgan et al. 2004). As a risk factor
for glaucoma progression (Leske
2009), there is a possibility that these
patients have a much lower than
mathematically expected perfusion
pressure. Additionally, central retinal
vessels had lower velocities in patients
without venous pulsation. As
decreased peak systolic velocities in
the central retinal artery have been
implicated in increased glaucoma pro-
gression (Zeitz et al. 2006), this com-
Table 4. CDI variables of the retrobulbar vessels in the experimental groups.
Healthy cm ⁄ s (SD) POAG cm ⁄ s (SD) NTG cm ⁄ s (SD) Overall p-value Pairwise POAG versus NTG p-value
CRA PSV 11.9 (4.3) 10.1 (3.1) 10.7 (3.4) 0.04 0.56
EDV 3.20 (1.2) 2.70 (0.9) 2.96 (1.1) 0.01 0.11
RI 0.72 (0.1) 0.73 (0.1) 0.71 (0.1) 0.70 0.43
MFV 6.42 (2.3) 5.50 (1.7) 5.75 (1.9) 0.04 0.60
CRV Vmax 5.89 (1.6) 5.13 (1.3) 5.32 (1.5) <0.01 0.47
Vmin 3.40 (0.8) 3.09 (0.6) 3.08 (0.7) <0.01 0.42
RI 0.41 (0.1) 0.38 (1.0) 0.41 (0.1) 0.08 0.07
NPCA PSV 9.29 (2.7) 9.51 (2.9) 9.51 (2.8) 0.73 0.88
EDV 3.13 (1.1) 3.15 (1.0) 3.2 (1.0) 0.77 0.65
RI 0.66 (0.1) 0.70 (0.4) 0.66 (0.1) 0.84 0.69
MFV 5.50 (1.8) 5.59 (1.8) 5.69 (1.7) 0.68 0.74
TPCA PSV 8.97 (2.4) 9.90 (1.8) 9.20 (2.7) 0.06 0.09
EDV 3.08 (0.9) 3.37 (1.1) 3.06 (0.9) 0.16 0.12
RI 0.65 (0.1) 0.65 (0.1) 0.66 (0.1) 0.78 0.64
MFV 5.40 (1.4) 6.00 (1.8) 5.44 (1.5) 0.06 0.06
OA PSV 37.7 (17) 31.7 (11) 31.6 (10) 0.04 0.99
EDV 6.85 (3.9) 5.93 (3.0) 5.81 (3.7) 0.26 0.53
RI 0.82 (0.1) 0.81 (0.1) 0.82 (0.1) 0.52 0.27
MFV 16.8 (8.7) 14.2 (5.2) 14.4 (6.1) 0.25 0.78
Data shown as mean velocities (SD). Overall comparison between the subgroups was made using Kruskal–Wallis test. Mann–Whitney tests were
used in pairwise comparison. NTG = normal tension glaucoma; POAG = primary open-angle glaucoma; CRA = central retinal artery;
CRV = central retinal vein; NPCA and TPCA = short posterior ciliary arteries (nasal and temporal = respectively); OA = ophthalmic artery;
PSV = peak systolic velocity; EDV = end diastolic velocity; RI = resistive index; MFV = mean ﬂow velocity; Vmax = maximum velocity;
Vmin = minimum velocity.
Table 5. CDI variables of the retrobulbar vessels according to SVP status.
Healthy POAG NTG
SVP+
cm ⁄ s (SD)
SVP)
cm ⁄ s (SD)
SVP+
cm ⁄ s (SD)
SVP)
cm ⁄ s (SD)
SVP+
cm ⁄ s (SD)
SVP)
cm ⁄ s (SD)
CRA PSV 12.1 (4.4) 11.1 (3.8) 10.2 (3.6) 10.0 (2.6) 11.8 (3.4) 9.46 (3.0)***
EDV 3.21 (1.1) 3.14 (1.4) 2.73 (1.0) 2.67 (0.8) 3.10 (1.0) 2.81 (1.2)
RI 0.72 (0.1) 0.73 (0.1) 0.72 (0.1) 0.72 (0.1) 0.73 (0.1) 0.70 (0.1)
MFV 6.45 (2.3) 6.23 (2.5) 5.52 (2.0) 5.47 (1.4) 6.19 (1.8) 5.27 (1.9)*
CRV Vmax 5.77 (1.5) 6.54 (1.9) 5.31 (1.3) 4.94 (1.4) 5.68 (1.7) 4.78 (0.9)**
Vmin 3.32 (0.7) 3.84 (1.1)* 3.07 (0.6) 2.67 (0.83)** 3.13 (0.7) 2.90 (0.4)
RI 0.41 (0.1) 0.40 (0.1) 0.40 (0.1) 0.35 (0.1)* 0.43 (0.1) 0.38 (0.1)*
NPCA PSV 9.31 (2.8) 9.22 (2.7) 9.30 (2.6) 9.71 (3.2) 9.43 (2.8) 9.62 (2.8)
EDV 3.11 (1.0) 3.23 (1.3) 2.98 (0.8) 3.30 (1.2) 3.07 (0.9) 3.35 (1.1)
RI 0.66 (0.1) 0.65 (0,1) 0.67 (0.1) 0.66 (0.1) 0.66 (0.1) 0.65 (0.1)
MFV 5.46 (1.8) 5.83 (1.7) 5.31 (1.6) 5.85 (2.0) 5.52 (1.5) 5.88 (1.9)
TPCA PSV 8.80 (2.5) 9.75 (2.0) 10.2 (3.1) 9.64 (2.4) 9.44 (2.7) 8.93 (2.6)
EDV 3.01 (0.8) 3.42 (1.1) 3.27 (0.9) 3.47 (1.2) 3.01 (0.8) 3.06 (0.9)
RI 0.65 (0.1) 0.64 (0.1) 0.67 (0.1) 0.63 (0.1) 0.66 (0.1) 0.65 (0.1)
MFV 5.28 (1.4) 5.94 (1.4) 6.02 (1.8) 5.98 (1.8) 5.54 (1.5) 5.33 (1.5)
OA PSV 38.5 (17) 33.1 (9.9) 32.0 (12) 31.6 (8.8) 31.2 (10) 32.1 (11)
EDV 7.04 (4.0) 5.86 (3.6) 5.34 (2.7) 6.44 (3.2) 5.30 (2.3) 6.34 (4.7)
RI 0.82 (0.1) 0.82 (0.1) 0.83 (0.1) 0.80 (0.1) 0.83 (0.1) 0.81 (0.1)
MFV 17.4 (9.1) 13.8 (5.7) 13.8 (5.6) 14.7 (4.9) 13.7 (5.2) 15.1 (7.0)
Data shown as mean (SD) with velocities indicated as cm ⁄ s. Comparison between the subgroups was made using Mann–Whitney tests. *,**,***
indicated statistically signiﬁcant differences in pairwise comparison with SVP+ counterpart (p < 0.05; p < 0.02; p < 0.01, respectively).
SVP = spontaneous venous pulsation; NTG = normal tension glaucoma; POAG = primary open-angle glaucoma; CRA = central retinal
artery; CRV = central retinal vein; NPCA and TPCA short posterior ciliary arteries (nasal and temporal, respectively); OA = ophthalmic artery;




bined arterial and venous decrease in
ocular blood ﬂow may signal an even
wider vascular dysfunction.
Interestingly, the increased func-
tional damage seen in non-pulsating
NTG patient is not accompanied by a
similar difference in structural damage
assessment. The link between func-
tion–structure in glaucoma is still
under debate and nonlinear relation-
ships have been proposed (Hood &
Kardon 2007; Harwerth et al. 2010).
Our results raise the possibility that
the increase in venous pressure and
consequent decrease in perfusion
could lead to a metabolic impairment
of the retinal cells, especially if associ-
ated with a local increase in vasocon-
strictive agents. A consequent decrease
in cellular activity could provide an
additional explanation for this func-
tional ⁄ structural mismatch. This
hypothesis, however, needs to be veri-
ﬁed by further studies on the metabolic
activity of retinal cells in these
patients.
Interestingly, POAG patients with
an absent SVP phenomenon had
higher diastolic pressures than their
SVP positive counterparts. As dia-
stolic pressure has been described as
an independent risk factor for CRV
occlusion (Arakawa et al. 2012), the
lack of a visible SVP in POAG
patients may, therefore, signal an
increased risk for developing this reti-
nal vascular disease. This hypothesis,
however, needs to be conﬁrmed by
further studies.
Healthy patients without a SVP
had higher minimal venous velocities.
While the statistical signiﬁcance of
this ﬁnding has to be taken cau-
tiously, this increase in Vmin without
the consequent increase in Vmax
could theoretically decrease venous
pulsatility. Such decreases are seen in
venous stasis conditions, such as
lower limb vein or portal vein throm-
bosis (Hamper et al. 2007; Labropou-
los et al. 2007).
Our work has several limitations.
While the SVP phenomenon is clini-
cally and easily assessed, the amount
of additional venous retinal pressure
implied by the non-pulsating vein
remained undisclosed. Additionally,
the venous output may have been
altered by the ocular compression
implied by tests used prior to the SVP
assessment. While careful attention
was paid not to exert pressure on the
eye, the possibility of these measure-
ments could have potentially inter-
fered with the observation of this
phenomenon has to be considered.
However, because of the need of a
mydriatic agent, SVP assessment was
necessarily put in last place. One con-
founding factor that needs to be taken
into account is that blood pressure
medications were not discontinued.
While blood pressure per se has been
suggested not to be related to retinal
venous pressure (Jonas 2004a,b), cer-
tain classes of medications can poten-
tially interfere with the ocular venous
tone. For instance, calcium channel
blockers may block the vasoactive
response of endothelin (Delgado et al.
2010).
Furthermore, the statistical analysis
comparing the healthy subgroups
should be considered carefully, as
despite our series being by far the
largest on the subject yet published,
the study is still underpowered to fully
address these questions. As such, any
interpretation of both signiﬁcant and
nonsigniﬁcant p values of any com-
parison between healthy patients with
and without SVP should be looked at
cautiously.
In summary, our work suggests the
easy to assess SVP phenomenon to be
of clinical importance in glaucoma.
Moreover, we demonstrate that
glaucoma patients have decreased
venous velocities in the CRV. While
further studies on the venous circula-
tion are still needed, this work em-
phasises that venous pulsations may
be particularly important in NTG
patients, where their absence may sig-
nal not only a wider vascular dysfunc-
tion but also a more advance stage of
the disease.
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